Please read Drs. Radovick and Sonnenberg’s article in the Journal of Allergy and Clinical Immunology titled, “Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches.“
Clinical trials are a fundamental tool in evaluating the safety and efficacy of new drugs, medical devices, and health system interventions. Clinical trial visits generally involve eligibility assessment, enrollment, intervention administration, data collection, and follow-up, with many of these steps performed during face-to-face visits between participants and the investigative team. Social distancing, which emerged as one of the mainstay strategies for reducing the spread of SARS-CoV-2, has presented a challenge to the traditional model of clinical trial conduct, causing many research teams to halt all in-person contacts except for life-saving research. Nonetheless, clinical research has continued during the pandemic because study teams adapted quickly, turning to virtual visits and other similar methods to complete critical research activities. To read the full article.
Clinical research during the COVID-19 pandemic: The role of virtual visits and digital approaches. Loucks TL, Tyson C, Dorr D, Garovic VD, Hill J, McSwain SD, Radovick S, Sonnenberg FA, Weis JA, Brady KT. J Clin Transl Sci. 2021 Mar 8;5(1):e102. PMID: 34192057 PMCID: PMC8185429 DOI: 1017/cts.2021.19